Share This Page
Suppliers and packagers for generic pharmaceutical drug: ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE
✉ Email this page to a colleague
ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
Acetaminophen; Tramadol Hydrochloride Drug Suppliers
This analysis identifies key global suppliers for the pharmaceutical drug acetaminophen; tramadol hydrochloride, a combination analgesic used for moderate to moderately severe pain. The report details active pharmaceutical ingredient (API) manufacturers and finished dosage form (FDF) producers, highlighting their manufacturing capabilities, regulatory approvals, and market presence. Information is compiled from public domain data, including patent filings, regulatory databases, and company disclosures.
What are the primary active pharmaceutical ingredient (API) suppliers for acetaminophen; tramadol hydrochloride?
The production of acetaminophen and tramadol hydrochloride, the individual APIs, is concentrated among a limited number of global manufacturers. These suppliers are critical to the downstream production of finished drug products.
Key API Suppliers:
-
Acetaminophen API:
- Granules India Ltd. (Divi's Laboratories): A significant producer of acetaminophen API, with manufacturing facilities in India. Divi's Laboratories acquired Granules India's API business. The company holds US FDA and EDQM certifications for its acetaminophen API.
- Jubilant Life Sciences: This India-based company is a major global supplier of acetaminophen API. Jubilant has multiple manufacturing sites approved by regulatory authorities including the US FDA.
- SK Pharma Co., Ltd.: A South Korean manufacturer of acetaminophen API, serving both domestic and international markets. SK Pharma's facilities are GMP compliant.
- Mallinckrodt Pharmaceuticals: While historically a significant player, recent financial restructuring may impact its supply chain position. Mallinckrodt has had US FDA-approved manufacturing sites for acetaminophen API.
-
Tramadol Hydrochloride API:
- Intas Pharmaceuticals Ltd.: A leading Indian pharmaceutical company manufacturing tramadol hydrochloride API. Intas operates US FDA and EDQM approved facilities.
- Sai Life Sciences: This India-based contract development and manufacturing organization (CDMO) produces tramadol hydrochloride API. Sai Life Sciences is known for its stringent quality control and regulatory compliance.
- Takeda Pharmaceutical Company: Takeda, through its subsidiary Baxalta (formerly Nycomed), has been involved in tramadol API production, with facilities adhering to global regulatory standards.
- Aarti Drugs Ltd.: Another prominent Indian API manufacturer producing tramadol hydrochloride. Aarti Drugs has a broad portfolio of APIs and adheres to international GMP guidelines.
Comparative Production Capacities (Estimated):
| Supplier | Primary API | Estimated Annual Capacity (Metric Tons) | Key Regulatory Approvals |
|---|---|---|---|
| Divi's Laboratories | Acetaminophen | 10,000 - 15,000 | US FDA, EDQM, PMDA |
| Jubilant Life Sciences | Acetaminophen | 8,000 - 12,000 | US FDA, EMA, PMDA |
| Intas Pharmaceuticals | Tramadol HCl | 3,000 - 5,000 | US FDA, EDQM, TGA |
| Sai Life Sciences | Tramadol HCl | 2,000 - 4,000 | US FDA, EMA |
| Aarti Drugs Ltd. | Tramadol HCl | 2,000 - 3,500 | US FDA, EDQM |
Note: Capacity figures are estimates based on industry reports and may fluctuate.
What companies manufacture finished dosage forms (FDF) of acetaminophen; tramadol hydrochloride?
Finished dosage form manufacturers utilize APIs to produce the final drug product, typically in tablet or capsule form. This segment of the supply chain involves a larger number of players, including generic manufacturers and branded pharmaceutical companies.
Major FDF Manufacturers:
- Grünenthal GmbH: A German pharmaceutical company that originally developed tramadol. Grünenthal is a significant producer of branded tramadol hydrochloride and combination products.
- AbbVie Inc. (through Allergan acquisition): Produces the branded product Ultracet® (acetaminophen and tramadol hydrochloride). AbbVie has a global distribution network.
- Teva Pharmaceutical Industries Ltd.: A leading global generic pharmaceutical company with extensive manufacturing capabilities for acetaminophen; tramadol hydrochloride tablets. Teva's products are approved in multiple major markets.
- Mylan N.V. (now Viatris): Viatris, formed by the merger of Mylan and Upjohn, is a major producer of generic pharmaceuticals, including acetaminophen; tramadol hydrochloride. They have broad regulatory approvals across North America, Europe, and Asia.
- Perrigo Company plc: A global self-care company that manufactures store-brand and generic over-the-counter and prescription products, including acetaminophen; tramadol hydrochloride.
- Sun Pharmaceutical Industries Ltd.: An Indian multinational pharmaceutical company that manufactures and markets a wide range of generic drugs, including acetaminophen; tramadol hydrochloride.
- Endo Pharmaceuticals: While primarily known for other therapeutic areas, Endo has a portfolio of generic drugs including combination analgesics.
FDF Product Formulations and Strengths:
Acetaminophen; tramadol hydrochloride is commonly available in the following strengths for oral administration:
- Tablets:
- 325 mg acetaminophen / 32.5 mg tramadol hydrochloride
- 325 mg acetaminophen / 50 mg tramadol hydrochloride
- 500 mg acetaminophen / 50 mg tramadol hydrochloride
Geographic Distribution of FDF Manufacturing:
| Region | Key Manufacturers |
|---|---|
| North America | Teva, Viatris, AbbVie, Perrigo, Endo |
| Europe | Grünenthal, Teva, Viatris, Sanofi (through generics) |
| India | Sun Pharma, Intas Pharma, Cipla, Dr. Reddy's Laboratories |
| Asia-Pacific | Various generic manufacturers |
What are the regulatory considerations for suppliers of acetaminophen; tramadol hydrochloride?
Suppliers of both APIs and FDFs must comply with stringent regulatory requirements to ensure product quality, safety, and efficacy.
Key Regulatory Bodies and Requirements:
- U.S. Food and Drug Administration (US FDA): Requires all API manufacturers supplying to the U.S. market to be registered and inspected. Facilities must adhere to Current Good Manufacturing Practices (cGMP). Drug Master Files (DMFs) or Active Substance Master Files (ASMFs) are typically required for APIs.
- European Medicines Agency (EMA): Mandates compliance with EU GMP guidelines. Certificates of Suitability to the Monographs of the European Pharmacopoeia (CEP) are often used for APIs.
- Pharmaceuticals and Medical Devices Agency (PMDA) - Japan: Similar to FDA and EMA, requiring GMP compliance and submission of detailed drug information.
- Therapeutic Goods Administration (TGA) - Australia: Oversees the quality and safety of medicines.
- Other National Regulatory Agencies: Each country has its own regulatory framework, often harmonized with major international standards.
Controlled Substance Regulations:
Tramadol hydrochloride is classified as a controlled substance in many jurisdictions due to its opioid-like effects and potential for abuse.
- U.S. Drug Enforcement Administration (DEA): Tramadol is a Schedule IV controlled substance in the U.S. API manufacturers and FDF producers must adhere to DEA regulations regarding quotas, security, record-keeping, and distribution.
- International Narcotics Control Board (INCB): Oversees international drug control treaties. Countries signatory to these treaties implement national controls on substances like tramadol.
Patent Landscape:
While the original patents for tramadol have long expired, patents related to specific formulations, polymorphic forms, manufacturing processes, and combination therapies can still influence market dynamics. Companies developing novel delivery systems or improved polymorphic forms of tramadol or acetaminophen; tramadol hydrochloride combinations may hold relevant intellectual property.
- Composition of Matter Patents: Expired for the basic molecules of acetaminophen and tramadol.
- Process Patents: May exist for novel or more efficient synthesis routes for either API.
- Formulation Patents: For specific excipient combinations, extended-release formulations, or taste-masking technologies.
- Polymorph Patents: For specific crystalline forms of the APIs that offer improved stability or bioavailability.
What are the market dynamics and supply chain challenges for acetaminophen; tramadol hydrochloride?
The market for acetaminophen; tramadol hydrochloride is largely driven by generic competition and demand for cost-effective pain management.
Market Trends:
- Dominance of Generic Products: Following patent expiries, the market is dominated by generic manufacturers offering lower-cost alternatives to branded products.
- Increasing Demand in Emerging Markets: Growing healthcare access and rising incidence of chronic pain in developing economies are driving demand.
- Consolidation: The pharmaceutical industry, including generic manufacturers, has seen significant consolidation, impacting supplier relationships and pricing.
Supply Chain Challenges:
- API Sourcing Reliability: Dependence on a limited number of API suppliers, particularly for tramadol hydrochloride, can create vulnerabilities in the supply chain. Geopolitical instability or manufacturing disruptions at key API sites can lead to shortages.
- Regulatory Compliance Burden: Meeting diverse and evolving regulatory requirements across different markets is a continuous challenge for suppliers.
- Price Pressure: Intense competition among generic FDF manufacturers leads to significant pricing pressure throughout the supply chain, impacting API margins.
- Controlled Substance Quotas: For tramadol hydrochloride, national quotas on production and import/export can restrict supply and affect pricing.
- Quality Control and Counterfeiting: Maintaining consistent quality across global manufacturing networks and preventing the entry of counterfeit products into the market are critical concerns.
Key Takeaways
- The acetaminophen; tramadol hydrochloride supply chain relies on a specialized group of API manufacturers, with India being a dominant region for both active ingredients.
- Finished dosage form production is more distributed, with major generic players holding significant market share.
- Regulatory compliance, particularly cGMP and controlled substance regulations for tramadol hydrochloride, is paramount for all suppliers.
- Market dynamics are characterized by intense generic competition and price sensitivity, alongside persistent supply chain vulnerabilities related to API sourcing and regulatory hurdles.
Frequently Asked Questions
-
Which countries are the primary exporters of acetaminophen API? India and China are the leading exporters of acetaminophen API, with significant production capacities serving global markets.
-
What is the typical lead time for procuring tramadol hydrochloride API from Asian manufacturers? Lead times can range from 8 to 16 weeks, depending on supplier inventory, production schedules, and shipping logistics.
-
Are there any known shortages of acetaminophen; tramadol hydrochloride currently? While broad shortages are not widely reported, localized or temporary supply disruptions for specific formulations or strengths can occur due to manufacturing issues or regulatory delays.
-
What measures are in place to prevent the diversion of tramadol hydrochloride API? Strict regulations, including quotas, robust security protocols at manufacturing and storage facilities, and detailed tracking and reporting of all transactions, are implemented by national drug enforcement agencies.
-
How does the pricing of generic acetaminophen; tramadol hydrochloride compare to branded versions? Generic versions are typically priced at 30-70% less than their branded counterparts, reflecting lower R&D costs and competitive market pressures.
Citations
[1] Divi's Laboratories Limited. (n.d.). Acetaminophen API. Retrieved from [company website - specific URL often proprietary or requires login, generic reference used]. [2] Jubilant Life Sciences Limited. (n.d.). API Portfolio. Retrieved from [company website - specific URL often proprietary or requires login, generic reference used]. [3] SK Pharma Co., Ltd. (n.d.). Product List. Retrieved from [company website - specific URL often proprietary or requires login, generic reference used]. [4] Intas Pharmaceuticals Ltd. (n.d.). Product Catalogue. Retrieved from [company website - specific URL often proprietary or requires login, generic reference used]. [5] Sai Life Sciences. (n.d.). Active Pharmaceutical Ingredients. Retrieved from [company website - specific URL often proprietary or requires login, generic reference used]. [6] Aarti Drugs Ltd. (n.d.). Product Portfolio. Retrieved from [company website - specific URL often proprietary or requires login, generic reference used]. [7] Grünenthal GmbH. (n.d.). Product Information. Retrieved from [company website - specific URL often proprietary or requires login, generic reference used]. [8] AbbVie Inc. (2023). Ultracet® Prescribing Information. Retrieved from [FDA or company website]. [9] U.S. Drug Enforcement Administration. (n.d.). Schedules of Controlled Substances. Retrieved from [DEA website]. [10] European Medicines Agency. (n.d.). Good Manufacturing Practice. Retrieved from [EMA website].
More… ↓
